TCL Archive Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer October 25, 2013
TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001